Mark Andrews

Catheter Ablation for the Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillators

Implantable Cardioverter-Defibrillators in Tetralogy of Fallot

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare Patients

Prevalence of the Congenital Long-QT Syndrome

Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure

A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling

Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy

An integrated encyclopedia of DNA elements in the human genome

Catheter ablation of electrical storm

Time Spent on Clinical Documentation

A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

Cardiac manifestations of myotonic dystrophy type 1

Small-Vessel Vasculitis

Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy

Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator

Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America

Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

Calcium's Role in Mechanotransduction during Muscle Development

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

The Failing Heart — An Engine Out of Fuel

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines

The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications

Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT‐CRT): Design and Clinical Protocol

ACCF/AHA New Insights Into the Methodology of Performance Measurement

Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION

Experiences of Driving and Driving Restrictions in Recipients With an Implantable Cardioverter Defibrillator-The Patient Perspective

ICD Implantation and Arrhythmia‐Free Survival in Patients with Depressed LV Function Following Surgery for Valvular Heart Disease

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death

Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction

Reconstructive surgery of postinfarction left ventricular aneurysms: techniques and unsolved problems

Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation

Percutaneous Repair or Surgery for Mitral Regurgitation

Risk of Fatal Arrhythmic Events in Long QT Syndrome Patients After Syncope

Cardiac Actions of Erythromycin

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

Antiarrhythmic effect of carvedilol after acute myocardial infarction

Ongoing right ventricular hemodynamics in heart failure

Dilated cardiomyopathy

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Noninvasive Risk Assessment Early After a Myocardial Infarction

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Performance of 3-Dimensional Echocardiography in Measuring Left Ventricular Volumes and Ejection Fraction

The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

Arrhythmia Risk Stratification with Regard to Prophylactic Implantable Defibrillator Therapy in Patients with Dilated Cardiomyopathy

Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Acute myocardial infarction

Predictors of All‐Cause Mortality for Patients with Chronic Chagas' Heart Disease Receiving Implantable Cardioverter Defibrillator Therapy

Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

Risk Factors for Recurrent Syncope and Subsequent Fatal or Near-Fatal Events in Children and Adolescents With Long QT Syndrome

Implantable Cardioverter Defibrillators in Patients with Valvular Cardiomyopathy

B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias

Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: A meta-analysis of >35,000 patients

Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)

Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure

HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials

Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction

Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With β-Blockers

ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article

Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long-Term Survival in the MADIT-II Trial

Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome

Behavioral-Independent Features of Complex Heartbeat Dynamics

Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure

Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators

The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis

Clinical experience with a novel subcutaneous implantable defibrillator system in a single center

EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)

Cardiac resynchronization therapy for congestive heart failure

Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy

The Role of the Wearable Cardioverter Defibrillator in Clinical Practice

European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support

Baseline characteristics of patients recruited into the CARE-HF study

Implantable Cardioverter-Defibrillator Shocks

Aggregate National Experience With the Wearable Cardioverter-Defibrillator

Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator

The Entirely Subcutaneous Implantable Cardioverter-Defibrillator

Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure

Heart failure

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary

Risk Stratification in the Long-QT Syndrome

Usefulness of Sleep-Disordered Breathing to Predict Occurrence of Appropriate and Inappropriate Implantable-Cardioverter Defibrillator Therapy in Patients With Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death

Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone

Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT)

Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator

Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT

Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure

Sudden Death Due to Cardiac Arrhythmias

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

Shock Anxiety among Implantable Cardioverter Defibrillator Recipients with Recent Tachyarrhythmia

Health-Related Quality of Life Consequences of Implantable Cardioverter Defibrillators

Novel therapeutics for treatment of long-QT syndrome and torsade de pointes

Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues

Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly

Comparison of Benefit and Mortality of Implantable Cardioverter–Defibrillator Therapy in Patients Aged ≥75 Years Versus Those <75 Years

Percent right ventricular pacing predicts outcomes in the DAVID trial

Implantable Cardioverter Defibrillator Therapy for Prevention of Sudden Cardiac Death in Children in The Netherlands

Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration: The Karolinska approach

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

Pediatric ICD utilization in the United States from 1997 to 2006

Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy

Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias

Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction

Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention

Wearable defibrillator use in heart failure (WIF): results of a prospective registry

Sarcoidosis

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: A multicenter case-control study

Expansion of Heart Failure Device Therapy Into a Rural Indigent Population in Louisiana: Potential Economic and Health Policy Implications

Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes

Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy

Drug-Induced Prolongation of the QT Interval

Gender differences in arrhythmias

Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease

Defibrillator Implantation Early after Myocardial Infarction

Biomarkers in Heart Failure

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Sudden Cardiac Death Risk Stratification in Patients With Nonischemic Dilated Cardiomyopathy

Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families

Long QT Syndrome in Children in the Era of Implantable Defibrillators

Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease

Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations

The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases

Use of implantable cardioverter-defibrillators for primary prevention in older patients: A systematic literature review and meta-analysis

Myocarditis

Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management

Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies

Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008

Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure

Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a

Impact of Viability, Ischemia, Scar Tissue, and Revascularization on Outcome After Aborted Sudden Death

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Sudden Cardiac Death in Adult Congenital Heart Disease

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

HIF-1α is required for development of the sympathetic nervous system

Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome

Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families

Perceived support from healthcare professionals, shock anxiety and post‐traumatic stress in implantable cardioverter defibrillator recipients

Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators

Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure

EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias

Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease

Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Modeling hepatitis C virus infection using human induced pluripotent stem cells

Incidence and Predictors of Sudden Cardiac Arrest in Adults With Congenital Heart Defects Repaired Before Adult Life

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death

Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2

Linking disease associations with regulatory information in the human genome

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration

Machine Learning in Medicine

Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death

Sudden Cardiac Death

Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic Dysfunction

Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device

Natural History of Brugada Syndrome

Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators

Nonvalvular Cardiovascular Device–Related Infections

The Year in Heart Failure 2005

Role of Transvenous Implantable Cardioverter-Defibrillators in Preventing Sudden Cardiac Death in Children, Adolescents, and Young Adults

Pathological Ventricular Remodeling

Epidemiology and Genetics of Sudden Cardiac Death

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Trifluoperazine, a calmodulin antagonist, inhibits muscle cell fusion.

Fractal dynamics in physiology: Alterations with disease and aging

Fibrosis — A Common Pathway to Organ Injury and Failure

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

Selection of patients for heart transplantationin the current era of heart failure therapy

Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy

Reactive Oxygen Species (ROS)-Based Nanomedicine

Dual-Chamber Pacing or Ventricular Backup Pacing in Patients With an Implantable Defibrillator

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction

2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

ACCF/AHA New Insights Into the Methodology of Performance Measurement

Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet

Genetic Characteristics of Children and Adolescents With Long-QT Syndrome Diagnosed by School-Based Electrocardiographic Screening Programs

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force

2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery

Long-Term Arrhythmia-Free Survival in Patients With Severe Left Ventricular Dysfunction and No Inducible Ventricular Tachycardia After Myocardial Infarction

Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention – is it necessary?

Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?

ANCA and associated diseases: immunodiagnostic and pathogenetic aspects

2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation

The Efficacy of Implantable Cardioverter-Defibrillators in Heart Transplant Recipients

Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene

Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis?

Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome

Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT‐II Substudy

Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction

Influence of the Genotype on the Clinical Course of the Long-QT Syndrome

Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients

Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II

Modulating effects of age and gender on the clinical course of long QT syndrome by genotype

Reduction in Ventricular Tachyarrhythmias With Statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II

The Cost Effectiveness of Implantable Cardioverter-Defibrillators

Occurrence, characteristics and prognostic significance of early postacute myocardial infarction angina pectoris

Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II

Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II)

Predictive Value of Ventricular Arrhythmia Inducibility for Subsequent Ventricular Tachycardia or Ventricular Fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Patients

Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II

Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators

Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy

Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II

Long QT Syndrome and Pregnancy

Corrected QT Variability in Serial Electrocardiograms in Long QT Syndrome

Effects of Beta-Blockers on Implantable Cardioverter Defibrillator Therapy and Survival in the Patients with Ischemic Cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II)

Differences in Outcomes Between Patients Treated with Single‐ versus Dual‐Chamber Implantable Cardioverter Defibrillators: A Substudy of the Multicenter Automatic Defibrillator Implantation Trial II

Temporal aspects of improved survival with the implanted defibrillator (MADIT-II)

QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients

Participation of calmodulin in immunoglobulin capping.

Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator

Increased Risk of Arrhythmic Events in Long-QT Syndrome With Mutations in the Pore Region of the Human Ether-a-go-go–Related Gene Potassium Channel

Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II

Long-QT Syndrome After Age 40

Influence of Pregnancy on the Risk for Cardiac Events in Patients With Hereditary Long QT Syndrome

Storms of ventricular tachycardia/fibrillation in MADIT II patients

The Cost-effectiveness of Automatic Implantable Cardiac Defibrillators:

Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome

Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction

Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome

Age- and Sex-Related Differences in Clinical Manifestations in Patients With Congenital Long-QT Syndrome